Efficacy of a New Small-Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) in Preclinical Models of B-Cell Lymphoma and Acute Myeloid Leukemia

被引：0
|
作者：
Perez-Salvia, Montserrat [1 ]
Eneko, Aldaba [2 ]
Yosu, Vara [2 ]
Myriam, Fabre [2 ]
Cristina, Ferrer [2 ]
Carme, Masdeu [3 ]
Aizpea, Zubia [3 ]
Sebastian Eider, San [3 ]
Dorleta, Otaegui [3 ]
Pere, Llinas-Arias [1 ]
Margalida, Rossello-Tortella [1 ]
Maria, Berdasco [1 ]
Fernando, Setien [1 ]
Catia, Moutinho [1 ]
Alberto, Villanueva [4 ]
Gonzalez-Barca, Eva [5 ]
Muncunill, Josep [6 ]
Tomas Navarro, Jose [6 ]
Angel Piris, Miguel [7 ]
Fernando, Cossio [3 ]
Esteller, Manel [1 ]
机构：
[1] Canc Epigenet & Biol Program PEBC, Barcelona, Spain
[2] Quimatryx, San Sebastian, Spain
[3] Univ Basque Country, San Sebastian, Spain
[4] Catalan Inst Oncol ICO, Barcelona, Spain
[5] Catalan Inst Oncol, Barcelona, Spain
[6] Josep Carreras Res Inst IJC, Badalona, Spain
[7] Fdn Jimenez Diaz, Madrid, Spain
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111578
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5383
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition
    René Winkler
    Ann-Sophie Mägdefrau
    Eva-Maria Piskor
    Markus Kleemann
    Mandy Beyer
    Kevin Linke
    Lisa Hansen
    Anna-Maria Schaffer
    Marina E. Hoffmann
    Simon Poepsel
    Florian Heyd
    Petra Beli
    Tarik Möröy
    Siavosh Mahboobi
    Oliver H. Krämer
    Christian Kosan
    Oncogene, 2022, 41 : 4560 - 4572
  • [22] Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition
    Winkler, Rene
    Magdefrau, Ann-Sophie
    Piskor, Eva-Maria
    Kleemann, Markus
    Beyer, Mandy
    Linke, Kevin
    Hansen, Lisa
    Schaffer, Anna-Maria
    Hoffmann, Marina E.
    Poepsel, Simon
    Heyd, Florian
    Beli, Petra
    Moroy, Tarik
    Mahboobi, Siavosh
    Kramer, Oliver H.
    Kosan, Christian
    ONCOGENE, 2022, 41 (40) : 4560 - 4572
  • [23] Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia
    Samir H. Barghout
    Parasvi S. Patel
    Xiaoming Wang
    G. Wei Xu
    Simon Kavanagh
    Ondrej Halgas
    Sara F. Zarabi
    Marcela Gronda
    Rose Hurren
    Danny V. Jeyaraju
    Neil MacLean
    Shawn Brennan
    Marc L. Hyer
    Allison Berger
    Tary Traore
    Michael Milhollen
    Adam C. Smith
    Mark D. Minden
    Emil F. Pai
    Razq Hakem
    Aaron D. Schimmer
    Leukemia, 2019, 33 : 37 - 51
  • [24] Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia
    Barghout, Samir H.
    Patel, Parasvi S.
    Wang, Xiaoming
    Xu, G. Wei
    Kavanagh, Simon
    Halgas, Ondrej
    Zarabi, Sara F.
    Gronda, Marcela
    Hurren, Rose
    Jeyaraju, Danny, V
    MacLean, Neil
    Brennan, Shawn
    Hyer, Marc L.
    Berger, Allison
    Traore, Tary
    Milhollen, Michael
    Smith, Adam C.
    Minden, Mark D.
    Pai, Emil F.
    Hakem, Razq
    Schimmer, Aaron D.
    LEUKEMIA, 2019, 33 (01) : 37 - 51
  • [25] Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma (vol 113, pg 13162, 2016)
    Hideshima, Teru
    Qi, Jun
    Paranal, Ronald M.
    Tang, Weiping
    Greenberg, Edward
    West, Nathan
    Colling, Meaghan E.
    Estiu, Guillermina
    Mazitschek, Ralph
    Perry, Jennifer A.
    Ohguchi, Hiroto
    Cottini, Francesca
    Mimura, Naoya
    Gorgun, Gullu
    Tai, Yu-Tzu
    Richardson, Paul G.
    Carrasco, Ruben D.
    Wiest, Olaf
    Schreiber, Stuart L.
    Anderson, Kenneth C.
    Bradner, James E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (10)
  • [26] Inhibition of Histone Deacetylase 6 (HDAC6) Disrupts the Tolerogenic STAT3 Signaling Pathway and Augments Antitumor Immune Responses in Mantle Cell Lymphoma (MCL)
    Wang, Hongwei
    Cheng, Fengdong
    Wang, Zi
    Lienlaf, Maritza
    Perez-Villarroel, Patricio
    Knox, Tessa
    Sahakian, Eva
    Pinilla-Ibarz, Javier
    Horna, Pedro
    Chen-Kiang, Selina
    Martin, Peter
    Bergman, Joel
    Kozikowski, Alan
    Villagra, Alejandro
    Tao, Jianguo
    Shah, Bijal D.
    Sotomayor, Eduardo M.
    BLOOD, 2012, 120 (21)
  • [27] HDAC6 Activates HGF/MET via Inhibition of HR23B in Diffuse Large B-cell Lymphoma
    Liu, Z.
    Cai, Y.
    Cui, W.
    Cao, B.
    Yu, B.
    Bi, R.
    Wei, P.
    Chen, W.
    Zhou, X.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 725 - 725
  • [28] Ricolinostat (ACY-1215), a Selective HDAC6 Inhibitor, Alone and in Combination with Bendamustine Is Effective in Preclinical Studies in Lymphoma Cell Lines
    Cosenza, Maria
    Civallero, Monica
    Quayle, Steven N.
    Sacchi, Stefano
    Pozzi, Samantha
    BLOOD, 2016, 128 (22)
  • [29] An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice
    Do, Anh
    Reid, Robert C.
    Lohman, Rink-Jan
    Sweet, Matthew J.
    Fairlie, David P.
    Iyer, Abishek
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 360 (01): : 140 - 151
  • [30] Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma
    Lin, Xiao-Ji
    Cai, Li-Meng
    Qian, Zi-Jun
    Wang, Chen-Yi
    Sun, Ni
    Sun, Xiao-Hai
    Huang, He
    Guo, Wen-Jian
    Lin, Hai-Yan
    Yao, Rong-Xin
    ONCOTARGETS AND THERAPY, 2017, 10 : 5129 - 5136
12345